1. Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL;
2. Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;
3. Division of Hematology/Oncology and
4. Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI;
5. Hematology/Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, NH;
6. Departments of Immunology and Medicine, Roswell Park Cancer Institute, Buffalo, NY;
7. Department of Oncology, Albert-Einstein Cancer Center–Montefiore Medical Center, Bronx, NY;
8. Hematology & Oncology, Rush University Medical Center, Chicago, IL;
9. Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL;
10. Division of Hematology/Oncology, Advocate Lutheran General Hospital, Park Ridge, IL;
11. Section of Hematology and Oncology, Department of Medicine, The University of Chicago, Chicago, IL;
12. Department of Medicine, Section of Hematology-Oncology, University of Illinois at Chicago, Chicago, IL;
13. Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE;
14. Division of Hematology/Oncology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA;
15. Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI;
16. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;
17. Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA;
18. Division of Hematology/Oncology, Hackensack University Medical Center, Hackensack, NJ;
19. Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ;
20. Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL;
21. Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN;
22. Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA;
23. Division of Hematology, The Ohio State University-James Comprehensive Cancer Center, Columbus, OH;
24. Leukemia/BMT Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada;
25. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
26. Department of Pathology, MD Anderson Cancer Center, Houston, TX; and
27. Department of Pathology and
28. Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA